Envista (NVST) Competitors $20.39 +0.22 (+1.09%) As of 01:10 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NVST vs. SNN, SOLV, PEN, STVN, GKOS, IRTC, NARI, TMDX, BLCO, and SLNOShould you be buying Envista stock or one of its competitors? The main competitors of Envista include Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), iRhythm Technologies (IRTC), Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry. Envista vs. Its Competitors Smith & Nephew SNATS Solventum Penumbra Stevanato Group Glaukos iRhythm Technologies Inari Medical TransMedics Group Bausch + Lomb Soleno Therapeutics Smith & Nephew SNATS (NYSE:SNN) and Envista (NYSE:NVST) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment. Which has stronger valuation & earnings, SNN or NVST? Smith & Nephew SNATS has higher revenue and earnings than Envista. Envista is trading at a lower price-to-earnings ratio than Smith & Nephew SNATS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmith & Nephew SNATS$5.81B2.28$412M$2.1614.02Envista$2.50B1.38-$1.12B-$6.53-3.12 Is SNN or NVST more profitable? Smith & Nephew SNATS has a net margin of 0.00% compared to Envista's net margin of -44.90%. Envista's return on equity of 4.07% beat Smith & Nephew SNATS's return on equity.Company Net Margins Return on Equity Return on Assets Smith & Nephew SNATSN/A N/A N/A Envista -44.90%4.07%2.25% Do insiders and institutionals hold more shares of SNN or NVST? 25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 1.0% of Smith & Nephew SNATS shares are owned by insiders. Comparatively, 1.3% of Envista shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer SNN or NVST? In the previous week, Envista had 3 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 4 mentions for Envista and 1 mentions for Smith & Nephew SNATS. Smith & Nephew SNATS's average media sentiment score of 1.43 beat Envista's score of 0.74 indicating that Smith & Nephew SNATS is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smith & Nephew SNATS 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer SNN or NVST? Smith & Nephew SNATS currently has a consensus target price of $28.00, suggesting a potential downside of 7.53%. Envista has a consensus target price of $20.23, suggesting a potential downside of 0.78%. Given Envista's stronger consensus rating and higher probable upside, analysts clearly believe Envista is more favorable than Smith & Nephew SNATS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smith & Nephew SNATS 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Envista 1 Sell rating(s) 9 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.33 Which has more volatility and risk, SNN or NVST? Smith & Nephew SNATS has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Comparatively, Envista has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500. SummaryEnvista beats Smith & Nephew SNATS on 9 of the 17 factors compared between the two stocks. Get Envista News Delivered to You Automatically Sign up to receive the latest news and ratings for NVST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NVST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVST vs. The Competition Export to ExcelMetricEnvistaMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$3.46B$10.33B$5.49B$20.61BDividend YieldN/A2.09%5.39%3.77%P/E Ratio-3.1216.7427.4328.03Price / Sales1.3829.51398.6637.14Price / Cash12.0522.7836.1321.91Price / Book1.203.668.024.59Net Income-$1.12B$235.40M$3.16B$984.95M7 Day Performance3.63%1.89%2.21%2.86%1 Month Performance8.89%3.83%4.50%5.43%1 Year Performance25.09%-10.25%36.02%14.59% Envista Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVSTEnvista3.6032 of 5 stars$20.39+1.1%$20.23-0.8%+23.5%$3.46B$2.50B-3.1212,700SNNSmith & Nephew SNATS3.7776 of 5 stars$29.17+1.2%$28.00-4.0%+22.2%$12.77B$5.81B13.5017,349SOLVSolventum0.9013 of 5 stars$73.21-0.5%$80.29+9.7%+51.6%$12.67B$8.31B33.8922,000Positive NewsAnalyst UpgradePENPenumbra4.7339 of 5 stars$254.41-1.0%$302.40+18.9%+41.8%$9.85B$1.19B240.014,500Positive NewsSTVNStevanato Group0.9763 of 5 stars€23.62+1.4%N/A+36.2%€7.15B€1.19B46.315,521Positive NewsAnalyst ForecastGap DownGKOSGlaukos4.3607 of 5 stars$96.80-3.3%$134.67+39.1%-12.8%$5.53B$383.48M-40.84780IRTCiRhythm Technologies1.1904 of 5 stars$150.95+3.6%$138.60-8.2%+44.8%$4.82B$591.84M-48.072,000Insider TradeNARIInari Medical0.4681 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800TMDXTransMedics Group1.6056 of 5 stars$127.53+3.2%$127.33-0.2%-14.3%$4.31B$441.54M93.77210Positive NewsBLCOBausch + Lomb3.3757 of 5 stars$12.01+2.3%$15.54+29.5%-6.2%$4.25B$4.79B-11.6613,500SLNOSoleno Therapeutics4.2152 of 5 stars$81.42+1.8%$107.10+31.5%+117.0%$4.10BN/A-17.6230 Related Companies and Tools Related Companies Smith & Nephew SNATS Alternatives Solventum Alternatives Penumbra Alternatives Stevanato Group Alternatives Glaukos Alternatives iRhythm Technologies Alternatives Inari Medical Alternatives TransMedics Group Alternatives Bausch + Lomb Alternatives Soleno Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NVST) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envista Holdings Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Envista With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVST Stock Alerts